Daisy Pharma Opioid Venture, LLC — Form D
Daisy Pharma Opioid Venture, LLC of SCOTTSDALE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-06. The offering totals $75.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2018-02-06
- Form: D
- Accession: 0001729659-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $75.0M
- Remaining: $75.0M
- Minimum investment: $1.0M
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-304949
Issuer
- Name: Daisy Pharma Opioid Venture, LLC
- CIK: 0001729659
- Entity type: Limited Liability Company
- Jurisdiction: ARIZONA
- Incorporated: 2017
- Address: 23623 N. Scottsdale Rd., #D3269, SCOTTSDALE, AZ, 85255
- Phone: 480-355-9000
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Brent Berj Nerguizian | Executive Officer | Scottsdale, AZ |
| Kendric Burton Speagle | Executive Officer | Scottsdale, AZ |
More